Previous Close | 0.0870 |
Open | 0.0890 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.0700 - 0.1000 |
52 Week Range | 0.0021 - 0.1300 |
Volume | 407,862 |
Avg. Volume | 250,206 |
Market Cap | 14.334M |
Beta (5Y Monthly) | 3.86 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1490 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Toronto, Ontario--(Newsfile Corp. - January 25, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, today announced that it has entered into the definitive agreement in respect of the previously announced (see press release dated January 12, 2021) proposed acquisition of Sairiyo Therapeutics Inc. ("Sairiyo") on January 12, ...
VANCOUVER, BC, Jan. 12, 2021 /CNW/ - Trading resumes in:Company: Pharmadrug Inc.
Toronto, Ontario--(Newsfile Corp. - January 12, 2021) - Â PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce that it has entered into a binding letter of intent (the "LOI"), dated January 11, 2021, to acquire Sairiyo Therapeutics Inc. ("Sairiyo") (the "Acquisition"). Sairiyo is a biotechnology ...